BR0215904A - Métodos e composições para prover glutamina - Google Patents

Métodos e composições para prover glutamina

Info

Publication number
BR0215904A
BR0215904A BR0215904-0A BR0215904A BR0215904A BR 0215904 A BR0215904 A BR 0215904A BR 0215904 A BR0215904 A BR 0215904A BR 0215904 A BR0215904 A BR 0215904A
Authority
BR
Brazil
Prior art keywords
glutamine
formulas
compositions
acetyl
acceptable salt
Prior art date
Application number
BR0215904-0A
Other languages
English (en)
Inventor
Jeffrey H Baxter
Jose Maria Lopez
Ricardo Rueda
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of BR0215904A publication Critical patent/BR0215904A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula

Abstract

"MéTODOS E COMPOSIçõES PARA PROVER GLUTAMINA". Métodos e composições para prover suplementação glutamina a um humano mediante administrar de modo oral uma quantidade eficaz de N-acetil-L-glutamina ou de um seu sal nutricionalmente aceitável. A N-acetil-L-glutamina ou um seu sal nutricionalmente aceitável pode ser incorporada dentro de uma composição líquida que é adequada para consumo humano. Exemplos de composições adequadas incluem soluções aquosas tais como para uso como soluções orais de reidratação e fórmulas nutricionais líquidas (incluindo fórmulas enterais, fórmulas orais, fórmulas para adultos, fórmulas para crianças e fórmulas para bebês). A quantidade de N-acetil-L-glutamina ou de um seu sal nutricionalmente aceitável pode variar amplamente, mas tipicamente, essas composições irão conter suficiente N-acetil-L-glutamina ou um seu sal nutricionalmente aceitável para prover pelo menos 140 mg da glutamina total por kg de peso corporal por dia.
BR0215904-0A 2002-10-08 2002-10-08 Métodos e composições para prover glutamina BR0215904A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97310502A 2002-10-08 2002-10-08
PCT/US2002/032172 WO2004032653A1 (en) 2002-10-08 2002-10-08 Methods and compositions for providing glutamine

Publications (1)

Publication Number Publication Date
BR0215904A true BR0215904A (pt) 2005-08-09

Family

ID=32094311

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0215904-0A BR0215904A (pt) 2002-10-08 2002-10-08 Métodos e composições para prover glutamina

Country Status (10)

Country Link
EP (1) EP1555896A1 (pt)
KR (1) KR20050071562A (pt)
CN (1) CN100382796C (pt)
AU (1) AU2002356547A1 (pt)
BR (1) BR0215904A (pt)
CA (1) CA2501540A1 (pt)
MX (1) MXPA05003732A (pt)
NZ (1) NZ539139A (pt)
WO (1) WO2004032653A1 (pt)
ZA (1) ZA200502843B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013204912B2 (en) * 2005-08-11 2016-12-01 Adetherapeutics, Inc. Reducing post-operative adhesion formation with intraperitoneal glutamine
SI1940439T1 (sl) 2005-08-11 2011-02-28 Univ Saskatchewan Zmanjĺ anje nastanka postoperativne adhezije z intraperotonealnim glutaminom
AU2016266102B2 (en) * 2005-08-11 2018-04-26 Adetherapeutics, Inc. Reducing post-operative adhesion formation with intraperitoneal glutamine
BRPI0718384A2 (pt) * 2006-10-19 2013-11-12 Nestec Sa Alimentação a longo prazo para pacientes com câncer
CA2578647A1 (en) * 2007-02-15 2008-08-15 University Of Saskatchewan Reducing post-operative adhesion formation with intraperitoneal glutamine
WO2010082390A1 (ja) * 2009-01-19 2010-07-22 ニュートリー株式会社 低濃度の栄養組成物
FR2955743B1 (fr) * 2010-02-03 2016-04-29 Roquette Freres Confiseries aux proteines de pois
EP2612560A1 (en) * 2012-01-09 2013-07-10 N.V. Nutricia Glutamine enriched nutritional composition for preterm infants
WO2014109632A1 (en) * 2013-01-09 2014-07-17 N.V. Nutricia Improvement of cognitive function in preterm infants that are small for gestational age
CN103070295B (zh) * 2013-01-31 2015-05-27 武汉工业学院 一种增进畜禽肠道屏障功能的饲料添加剂及其应用
US20140242216A1 (en) * 2013-02-24 2014-08-28 Mead Johnson Nutrition Company Amino Acid And Protein Hydrolysate Based Formulas With A Stable Emulsion System
US11234949B2 (en) * 2015-05-14 2022-02-01 Professional Dietetics S.P.A. Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy
US10525016B2 (en) 2015-06-03 2020-01-07 Mead Johnson Nutrition Company Nutritional compositions containing an elevated level of inositol and uses thereof
KR102598794B1 (ko) * 2018-01-29 2023-11-07 (주)아모레퍼시픽 소수성 아미노산을 포함하는 액상 조성물
WO2020247438A1 (en) 2019-06-03 2020-12-10 Vital Proteins LLC Recover dietary supplement
DE202021102589U1 (de) 2020-12-15 2021-05-28 Marco Lautenschläger Verzehrfertiges, abgefülltes Getränk auf Basis eines natürlichen Mineralwassers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR769M (pt) * 1960-11-25 1961-08-28
NO131985C (pt) * 1970-06-05 1975-09-03 Kyowa Hakko Kogyo Kk
US3944681A (en) * 1974-01-11 1976-03-16 General Foods Corporation Foods containing salts of acetyl amino acids as water binders
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor
SE9003844L (sv) * 1990-12-03 1992-06-04 Kabi Pharmacia Ab Naeringstillsats
GB9121467D0 (en) * 1991-10-10 1991-11-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
CN1126541C (zh) * 1999-12-03 2003-11-05 中国人民解放军军事医学科学院放射医学研究所 新型复合氨基酸组合物
GB0008249D0 (en) * 2000-04-04 2000-05-24 Mars Uk Ltd Supplementation of engine feedstuffs

Also Published As

Publication number Publication date
WO2004032653A1 (en) 2004-04-22
CN1717184A (zh) 2006-01-04
ZA200502843B (en) 2006-10-25
NZ539139A (en) 2007-11-30
MXPA05003732A (es) 2005-09-30
KR20050071562A (ko) 2005-07-07
EP1555896A1 (en) 2005-07-27
CA2501540A1 (en) 2004-04-22
CN100382796C (zh) 2008-04-23
AU2002356547A1 (en) 2004-05-04

Similar Documents

Publication Publication Date Title
BR0215904A (pt) Métodos e composições para prover glutamina
ES2528405T3 (es) Composición nutricional de bajo contenido calórico y alto en proteína para la estimulación de la síntesis de proteína muscular
VAN WOERT et al. Therapy of intention myoclonus with L‐5‐hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486
HRP20121072T1 (hr) Postupci za davanje tetrahidrobiopterina, povezani pripravci i postupci mjerenja
KR920000324A (ko) 필수 지방산 처리법
PT1337236E (pt) Suplemento a ser administrado entericamente para alimentacao parenterica ou paraalimentacao parcial enterica/ oral de doentes em estado critico, doentes cronicos e de pessoas mal nutridas
PL405077A1 (pl) Zastosowanie alpha-cyklodrkstryny do wytwarzania leku do zmniejszania biegunki
ES2570774T3 (es) Uso de ácido araquidónico para reducir el riesgo de resistencia a la insulina más adelante en la vida
BR9909872A (pt) uso de dexmedetomidina para uma unidade de sedação de proteção intensiva
KR970025615A (ko) 암 전이 억제제
PT1446112E (pt) Utilização de glutamato, derivados ou metabolitos de glutamato, análogos de glutamato ou misturas dos mesmos para o fabrico de uma composição para o tratamento da osteoporose
EP4008401A1 (en) Composition for cartilage regeneration promotion
JP4390428B2 (ja) 含カルシウム組織強化剤
BRPI0409935A (pt) composição para aperfeiçoar percepção e memória
JPS61500496A (ja) 膵臓のランゲルハンス島のインシュリン分泌を高めるためのシステイン誘導体またはその塩類の使用
CA2746902C (en) A multivitamin/mineral formulation to combat the effects of environmental stress; improve immunity and improve energy while addressing vitamin and mineral deficiencies without the negative side effects of a mega dose nutritional supplement
Wright et al. The role of" folic acid" and biotin in the utilization of pantothenic acid by the rat
BR0009380A (pt) Tratamento de câncer melhorado comtemozolomida
ES2250726T3 (es) Utilizacion de extractos de ginkgo biloba para preparar un medicamento destinado a tratar la sarcopenia.
BR0009643A (pt) Método para o uso de emamectina para o tratamento de parasitas de peixes
BR9914945A (pt) Processo para proporcionar terapiacosmética/medicinal
Chowdhury et al. Impact of lactational performance on bone mineral density in marginally-nourished Bangladeshi women
Shambaugh Sodium fluoride for inactivation of the otosclerotic lesion: present status
WO2019004984A2 (en) PHARMACEUTICAL FORMULATION COMPRISING CHOLECALCIFEROL
Karunakar et al. Acute methotrexate toxicity in psoriasis

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/195 (2006.01), A23L 33/16 (2016.01), A23L